BioLineRx (BLRX) Capital Expenditures (2010 - 2026)
BioLineRx (BLRX) posted Capital Expenditures of -$6,000 for the quarter ended Mar 31, 2026.
Powered by 
Analysis
BioLineRx (BLRX) Capital Expenditures (2010 - 2026) Analysis & Trends
For the trailing twelve months through Mar 31, 2026, Capital Expenditures at BioLineRx was -$27,000; for the year ended Dec 31, 2025, it was -$25,000.
- In prior years, BioLineRx's Capital Expenditures was -$53,000 in the year ended Dec 31, 2024, -$116,000 in the year ended Dec 31, 2023, -$131,000 in the year ended Dec 31, 2022 and -$97,000 in the year ended Dec 31, 2021.
- The figure for the quarter ended Mar 31, 2026 stands as the highest quarterly Capital Expenditures since the quarter ended Dec 31, 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 533.00 Mn |
| 10 | BioLineRx | 9.10 Mn | -67.42 Mn | 235,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -6,000.00 |
| Dec 31, 2024 | 112,000.00 |
| Sep 30, 2024 | -118,000.00 |
| Jun 30, 2024 | 91,000.00 |
| Mar 31, 2024 | -32,000.00 |
| Dec 31, 2023 | 216,000.00 |
| Sep 30, 2023 | -199,000.00 |
| Jun 30, 2023 | 131,000.00 |
| Mar 31, 2023 | -32,000.00 |
| Dec 31, 2022 | 205,000.00 |
| Sep 30, 2022 | -136,000.00 |
| Jun 30, 2022 | 80,000.00 |
| Mar 31, 2022 | -18,000.00 |
| Dec 31, 2021 | 132,000.00 |
| Sep 30, 2021 | -73,000.00 |
| Jun 30, 2021 | 57,000.00 |
| Mar 31, 2021 | -19,000.00 |
| Dec 31, 2020 | 1,000.00 |
| Sep 30, 2020 | -2,000.00 |
| Dec 31, 2019 | 121,000.00 |
API Access
BioLineRx Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();